Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Parkinson's Disease
60%
Mild Cognitive Impairment
25%
Parkinson
17%
Machine Learning
16%
Clinical Data
15%
Risk Factors
14%
Luxembourgish
13%
GBA1
12%
Disease Duration
12%
Long-read Sequencing
12%
Method Optimization
12%
Fecal Sample Collection
12%
Faecal DNA Extraction
12%
Cardiovascular History
12%
Prognostic Analysis
12%
Cross-cohort
12%
Authorship Criteria
12%
Metabolomics Data
12%
Outcome Prediction
12%
Gait Data
12%
Clinical Decision Support Tool
12%
Peripheral Whole Blood
12%
Polygenic Background
12%
Cardiovascular Risk
12%
Xanthine Metabolism
12%
Predictors of Cognitive Impairment
12%
Idiopathic PD
12%
Gut Microbiota
12%
Memory Impairment
12%
Variant Carriers
12%
Idiopathic Parkinson's Disease
12%
Moderate Pneumonia
12%
Major Risk
12%
Levodopa-induced Dyskinesia
12%
Health Effects
12%
Stool
12%
DNA Yield
12%
Cross-sectional Observational Study
12%
Post-COVID
12%
Stool Collection
8%
DNA Quality
8%
DNA Purity
8%
DNA Concentration
8%
Biobank
8%
DNA Extraction
8%
Supernatant
8%
Stabilizer
8%
Spectrofluorometry
8%
Spectrophotometry
8%
Parkinson's Disease-mild Cognitive Impairment
8%
Neuroscience
Parkinson's Disease
100%
Mild Cognitive Impairment
40%
Gut Microbiome
25%
Risk Factor
18%
Comorbidity
16%
Gait
12%
Cognitive Disorders
12%
L-DOPA
12%
Programmed Cell Death
12%
MicroRNA
12%
Memory Disorder
12%
COX-2 Inhibitor
12%
Progressive Supranuclear Palsy
12%
Cardiovascular System
12%
Dyskinesia
12%
SARS Coronavirus
6%
Subjective Cognitive Decline
6%
Cyclooxygenase 2
6%
Celecoxib
6%
Stereotypic Movement Disorder
5%
Medicine and Dentistry
Parkinson's Disease
62%
Gait
28%
Randomized Controlled Trial
25%
COVID-19
25%
Metabolomics
25%
Pneumonia
25%
Care Group
14%
Gut Microbiome
12%
Mild Cognitive Impairment
12%
Observational Study
12%
Anakinra
12%
Education
12%
Cardiovascular System
12%
Comorbidity
10%
Cardiovascular Disease
7%
Stereotypic Movement Disorder
6%
Diseases
5%
Unified Parkinson's Disease Rating Scale
5%
Levodopa
5%